Cargando…
Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy
Cancer diagnosis is currently undergoing a paradigm shift with the incorporation of molecular biomarkers as part of routine diagnostic panel. The molecular alteration ranges from those involving the DNA, RNA, microRNAs (miRNAs) and proteins. The miRNAs are recently discovered small non-coding endoge...
Autores principales: | Sethi, Seema, Ali, Shadan, Philip, Philip A., Sarkar, Fazlul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742272/ https://www.ncbi.nlm.nih.gov/pubmed/23863689 http://dx.doi.org/10.3390/ijms140714771 |
Ejemplares similares
-
Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity
por: Suresh, Raagini, et al.
Publicado: (2015) -
The Complexities of Epidemiology and Prevention of Gastrointestinal Cancers
por: Haq, Saba, et al.
Publicado: (2012) -
Recent updates on the role of microRNAs in prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2012) -
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
por: Bao, Bin, et al.
Publicado: (2011) -
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
por: Bao, Bin, et al.
Publicado: (2012)